Pfizer Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Strong return on equity (ROE 19.8%)
- Efficient capital deployment (ROCE 27.2%)
- Virtually debt-free
- Regular dividends — yield 2.1%
- Near 52-week low — potential value zone (₹3,589)
Concerns
- Premium to sector peers (P/E 108x vs industry 50.2x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
PFIZER · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% |
| FII | 3.03% | 3.32% | 3.22% | 3.54% | 2.74% | 2.18% |
| DII | 15.15% | 15.32% | 15.83% | 16.03% | 16.80% | 17.10% |
| Public | 17.87% | 17.42% | 17.00% | 16.50% | 16.54% | 16.79% |
Corporate Events
This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 3, 2026, inter alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter and half
To consider and approve the financial results for the period ended Jun 30, 2026
Dividend - Rs 75 Per Share
Dividend - Rs 35 Per Share & Special Dividend Of Rs 100 Per Share/ Special Dividend Of Rs 30
Dividend - Rs 35 Per Share
Dividend - Rs 35 Per Share/ Special Dividend - Rs 5 Per Share
Latest News
All newsPfizer Limited announces board meeting outcome.
*Pfizer Limited announces board meeting outcome.* The company disclosed the results of its board meeting held on September 7, 2026. No major strategic decisions or financial announcements were detailed in the filing. The update appears to be a routine corporate disclosure. 📊 *STOCKS:* $PFIZER | 🏢 *SECTOR:* Pharma | #LOWIMPACT #BoardMeeting
Pfizer reports Q1FY26 financial results
*Pfizer reports Q1FY26 financial results* — Pfizer Limited has announced its financial results for the quarter ended June 30, 2026. The outcome of the board meeting includes key financial metrics for the period, which may influence investor sentiment. Traders should review the detailed disclosures for revenue, profit figures, and guidance. 📊 *STOCKS:* PFIZER | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Earnings